SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-07-076590
Filing Date
2007-10-24
Accepted
2007-10-24 11:59:07
Documents
4
Group Members
WICHITA BIO CORPORATION

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a07-25268_5sc13da.htm SC 13D/A 73863
2 EX-1 a07-25268_5ex1.htm EX-1 21553
3 GRAPHIC g252687bci001.jpg GRAPHIC 2122
4 GRAPHIC g252687bci002.jpg GRAPHIC 3118
  Complete submission text file 0001104659-07-076590.txt   105018
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filed by) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154
Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700
BIOENVISION INC (Subject) CIK: 0001028205 (see all company filings)

IRS No.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-78274 | Film No.: 071187350
SIC: 2834 Pharmaceutical Preparations